Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cogane (PYM50028) in early-stage Parkinson's disease
2010-018534-44Phase 2Completed
- Sponsor
- Phytopharm plc
- Start
- Aug 2010
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Cogane with Placebo (2 arms). Primary endpoint: Change in UPDRS II/III score from baseline to Week 28. Started Aug 2010; status: completed.
02
Drugs
smilagenin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2010-018534-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018534-44.